|
TARDBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.023000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.470500E-02 |
| Normal-vs-Stage2 |
1.565560E-02 |
| Normal-vs-Stage3 |
1.52372999999706E-05 |
| Normal-vs-Stage4 |
4.001500E-04 |
| Stage1-vs-Stage2 |
2.676200E-01 |
| Stage1-vs-Stage3 |
1.003450E-03 |
| Stage1-vs-Stage4 |
4.880200E-02 |
| Stage2-vs-Stage3 |
3.331400E-01 |
| Stage2-vs-Stage4 |
7.962800E-01 |
| Stage3-vs-Stage4 |
3.932800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.550750E-04 |
| Normal-vs-AfricanAmerican |
1.162270E-02 |
| Normal-vs-Asian |
7.711200E-01 |
| Caucasian-vs-AfricanAmerican |
9.078200E-01 |
| Caucasian-vs-Asian |
1.524770E-01 |
| AfricanAmerican-vs-Asian |
1.836570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.64809999997551E-06 |
| Normal-vs-Female |
1.114170E-01 |
| Male-vs-Female |
3.958400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.318200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.376100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.774500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.725700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.003000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.188000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.973400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.549800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.359400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.713770E-01 |
| Normal-vs-Grade 2 |
1.188430E-01 |
| Normal-vs-Grade 3 |
1.33550000003257E-06 |
| Normal-vs-Grade 4 |
3.99979999998745E-06 |
| Grade 1-vs-Grade 2 |
6.144400E-02 |
| Grade 1-vs-Grade 3 |
3.178900E-04 |
| Grade 1-vs-Grade 4 |
4.177700E-04 |
| Grade 2-vs-Grade 3 |
1.89223000000016E-05 |
| Grade 2-vs-Grade 4 |
1.795860E-04 |
| Grade 3-vs-Grade 4 |
4.227600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.355800E-01 |
| Normal-vs-ccB subtype |
1.82370000212373E-08 |
| ccA subtype-vs-ccB subtype |
1.25010002349768E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.844900E-04 |
| Normal-vs-N1 |
3.642300E-03 |
| N0-vs-N1 |
2.883600E-01 |
|
|
